The trading price of our common stock (NYSE: EW) has risen significantly over the past several years. Edwards Lifesciences’ Board of Directors has evaluated the data demonstrating that our employees have a high level of interest and ownership in Edwards’ common stock as well as the feedback from those employees that a higher stock price can limit those who desire to invest in Edwards’ stock, especially those who are earlier in their careers. Because of this, we are pleased to perform a three-for-one split of our common stock.
A three-for-one split means that two new shares of stock are issued for each share in existence prior to the split. After the split, the stock price of each share is one-third of the stock price of each share immediately prior to the split but the total monetary value of all the shares is the same as before the stock split.
Here's an example:
Let’s assume that prior to the stock split, a shareholder owned 60 shares of Edwards’ stock and let's also assume that the market price of Edwards’ stock was $200 per share, so that the investment in Edwards was worth $12,000. Immediately after the split, the investor will own 180 shares of stock, but the market price will be $66.67 per share. The investor's total investment value in Edwards remains the same at $12,000 until the stock price moves up or down.
There are several key dates as follows:
- The Record Date, May 18, 2020, determines which stockholders are entitled to receive additional shares due to the split.
- The Distribution Date, May 29, 2020, is the date when the new shares are distributed by Computershare, our stock transfer agent.
- The Ex-Date or Ex-Split Date, June 1, 2020, is the date Edwards’ common stock will begin trading on the New York Stock Exchange at the new split-adjusted price.
Edwards’ stock will begin trading on the New York Stock Exchange at the new split-adjusted price on June 1, 2020, the Ex-Date or Ex-Split Date.
In a three-for-one stock split, the number of shares is tripled. This tripling is accomplished by issuing, or dividending, a similar number of new shares, resulting in three times as many shares as before the split.
The act of splitting the stock doesn’t change the overall value of a shareholder’s position in Edwards stock or Edwards as a company.
This stock split will not change the total value of a shareholder’s investment in Edwards’ stock.
No. Your accounts will be automatically adjusted to appropriately reflect the stock split.
Yes. Edwards had a two-for-one stock split in 2010 and a two-for-one stock split in 2015.
From a U.S. Federal tax standpoint, this is not a taxable event. Individual stockholders who reside outside of the U.S. should consult with their own tax adviser regarding their specific tax circumstances.
In terms of total value, your cost basis would remain the same. On a per share basis, your cost basis would be reduced by one-third, while the number of shares would be tripled.
Shortly after June 1, 2020, Computershare, our stock transfer agent, will mail a statement to registered stockholders who were owners as of May 18, 2020 indicating their split-adjusted shares. If your stock is currently held in a brokerage account, a statement will be sent directly from your broker. No action is required by you.
If your shares are held at Computershare, your split shares will be delivered to your account in electronic entry. If you have questions on your Computershare account, call them directly at 800-446-2617.
If your shares are held in a brokerage account, your split shares will be delivered to your account in electronic entry. Please contact your broker directly for additional information.
KEEP THEM. DO NOT DESTROY THEM. The stock certificates are still valid and should be kept in a safe place, as they are valuable documents.
Yes. Electronic accounts eliminate paper certificate processing and they are more efficient. Additionally, with an electronic account, shareholders don’t have to worry about the safekeeping of their paper certificates or paying costly fees to replace lost certificates.
What is common today in sharekeeping is to move away from paper stock certificates to electronic accounts. In keeping with this practice, Edwards’ shareholders will receive notice that their new shares have been deposited electronically into their account. As was the practice for our 2010 and 2015 split, no new certificates will be distributed with this stock split.
What is common today in sharekeeping is to move away from paper stock certificates to electronic accounts. Electronic accounts eliminate paper certificate processing and they are more efficient. Additionally, with an electronic account, shareholders don’t have to worry about the safekeeping of their paper certificates or paying costly fees to replace lost certificates.
Stockholders are encouraged to hold shares electronically. Contact your broker regarding the potential issuance of certificates.
There will not be a “when issued” market for the new split shares between the May 18, 2020 Record Date and May 29, 2020 Distribution Date.
Edwards’ shares will continue to trade at the pre-split price between the May 18 Record Date and the May 29 Distribution Date. Sellers who sell their shares before the Distribution Date are not entitled to the split shares they would have received by virtue of their being holders on the Record Date; sellers will receive full value for the shares they sell.
No, the par value will remain at $1.00 per share.
There will be no substantive impact to the company’s share repurchase program. Edwards’ share repurchase authorization is for a total dollar amount, not a total number of shares. Our repurchases are based on dollar amounts, which means we will be repurchasing triple the number of shares we would have prior to the split.
Since a stock split has no impact on the total value of the company, Edwards will be no more or less likely an acquisition candidate.
Since a stock split has no impact on the total value of the company, there would be no change in our ability to complete a major transaction.
Please contact the Computershare Customer Service Center at (800) 446-2617. For registered holders who have a non-U.S. address, please call (781) 575-2879.
You should contact your broker.
Edwards Lifesciences was incorporated in Delaware in 1999.
Please refer to our company Fact Sheet that is updated quarterly.
Edwards Lifesciences' headquarters are located in Irvine, California. The company has sales and manufacturing offices located throughout the world.
Edwards Lifesciences' facilities are primarily used for business purposes only and are not open to the public. Each year, we welcome all of our shareholders to the Annual Meeting of Stockholders which is typically held at our Irvine facility. Notice of the meeting, which is usually held in May, is included in the company's proxy statement.
We believe that we are a leading global competitor in each of our product lines. In Transcatheter Aortic Valve Replacement, our primary competitors include Medtronic PLC and Boston Scientific Corporation. In Surgical Structural Heart, our primary competitors include Medtronic PLC, Abbot Laboratories, and LivaNova PLC. In Critical Care, we compete primarily with a variety of companies in specific product lines including ICU Medical, Inc., PULSION Medical Systems SE, a subsidiary of Getinge AB, and LiDCO Group PLC. In Transcatheter Mitral and Tricuspid Therapies, our primary competitor is Abbot Laboratories, although there are a considerable number of large and small companies with development efforts in these fields.
Our fiscal year ends on December 31.
Fiscal quarters end on March 31 (Q1), June 30 (Q2), September 30 (Q3), and December 31 (Q4).
Yes. Edwards Lifesciences' quarterly earnings conference call is webcast live on the Investor Relations web site and is also available for replay afterwards. The Investor Relations web site provides details on how to register for the live webcast or listen to archived versions of previous earnings webcasts. Please click here for past webcasts.
Historical financial information about Edwards Lifesciences can be found on our Fundamentals page.
PricewaterhouseCoopers LLP currently serves as the independent registered public accounting firm for Edwards Lifesciences.
You should contact Edwards Lifesciences' transfer agent, Computershare at (800) 446-2617 or visit Computershare’s investor services website http://www.cis.computershare.com/contact.htm.
A transfer agent is hired by a publicly traded corporation to maintain records of who owns the company's stock and to track the stock purchases, sales, and account balances of registered shareholders. Edwards Lifesciences’ transfer agent, Computershare, keeps track of all outstanding stock certificates and the registered holder of those certificates. If an Edwards Lifesciences registered shareholder buys or sells Edwards stock, Computershare is responsible for transferring the ownership of that stock.
Shareholders can call Computershare's customer service at (800) 446-2617 for transfers, address changes, or any other questions regarding their Edwards Lifesciences stock certificates. You can also visit Computershare’s investor services website http://www.cis.computershare.com/contact.htm
A registered shareholder is the owner of the stock as recorded by the transfer agent. The registered shareholder's name appears on the stock certificate.
A transfer agent does not keep track of shares traded or held through brokerage accounts. Stocks that are held in a brokerage account are considered to be held in "street name," which means that those shares are held on behalf of the stockholder by the broker. In this case, the transfer agent considers the brokerage to be the registered shareholder. It is the responsibility of the brokerage to keep track of the accounts of their clients and to provide those clients with information regarding their Edwards Lifesciences shares, including the delivery of Proxy Statements.
You should contact Computershare at (800) 446-2617, or visit Computershare’s investor services website http://www.cis.computershare.com/contact.htm.
Lost stock certificates can be replaced by contacting Edwards Lifesciences’ transfer agent, Computershare, at (800) 446-2617, or visit Computershare’s investor services website http://www.cis.computershare.com/contact.htm.
Requests to transfer your certificates to another name or trust are handled by our transfer agent, Computershare, at (800) 446-2617, or visit Computershare’s investor services website http://www.cis.computershare.com/contact.htm..
Edwards' annual meeting of stockholders is typically held in May of each year at the company's corporate headquarters in Irvine, California. Notice of the meeting is included in the company's proxy statement.
The Proxy Statement is typically mailed to Edwards Lifesciences stockholders in early April.
Online Inquiry Form or mail correspondence to:
Computershare Investor Services
P.O. Box 43078
Providence, RI 02940-3078
250 Royall Street
Canton, MA 02021 Please note that Computershare is unable to accept a hand delivery of securities or instructions for securities from any other party than a nationally registered mail carrier.
Visit the tax cost basis page on this website.
If you hold your shares through a broker, then we do not, but your broker should. If you possess the stock certificate, please contact our transfer agent, Computershare, at (800) 446-2617, or visit Computershare’s investor services website http://www.cis.computershare.com/contact.htm..
You can reach Edwards Lifesciences Investor Relations department by calling toll free (800) 4-AHEART extension 2806, or (949) 250-2806. You can also contact us through our online investor information request form or send an email to Investor_Relations@edwards.com. Our mailing address is:
One Edwards Way
Irvine, CA 92614
On April 1, 2000, Edwards Lifesciences spun off from Baxter. At this time, shareholders were given 1 Edwards share for every 5 shares of Baxter stock. On May 27, 2010, Edwards issued a 100% stock dividend for purposes of effecting a two-for-one split of its common stock. Please click here for more information.
Edwards Lifesciences' ticker symbol is EW.
Our common stock is listed on the New York Stock Exchange under the symbol "EW."
Edwards Lifesciences has never paid any cash dividends on its capital stock and has no current plans to pay any cash dividends. Our current policy is to retain any future earnings to fund the growth and expansion of our business.
The CUSIP number for the stock is 28176E.
Please see our most recent financial statement by clicking here for the current number of shares outstanding.
Edwards Lifesciences stock can be purchased through just about any brokerage firm, including internet-based discount brokers. At the present time, Edwards Lifesciences does not offer a direct purchase program.
The Historical Stock Quote page on this website contains closing stock prices.
On May 7, 2020, Edwards stockholders approved the company’s plan to execute a 3-for-1 stock split. The split of the company’s outstanding shares of common stock will be effected in the form of a stock dividend of two shares of common stock to the holders of record of each share of Edwards’ common stock as of the close of business on May 18, 2020. The additional shares will be distributed on May 29, 2020. Please click here for more information.
On November 19, 2015, Edwards announced a two-for-one stock split to be issued as a 100% stock dividend. The record date is November 30, 2015. The distribution date is December 11, 2015. Edwards stock will begin trading on the NYSE at the new split-adjusted price on December 14, 2015.
On May 27, 2010, Edwards issued a 100% stock dividend for purposes of effecting a two-for-one split of its common stock. Please click here for more information.
On April 1, 2000, Edwards Lifesciences spun off from Baxter. At this time, shareholders were given 1 Edwards share for every 5 shares of Baxter stock. Click here for additional information to assist you in computing the tax basis.